Why a scientific paper on adverse events in Covid vaccination was withdrawn post-publication | India News – Times of India

The study titled “Long-term safety analysis of the BBV152 coronavirus vaccine in adolescents and adults: findings from a 1-year prospective study in north India,” which was published in May 2024 in the journal Drug Safety, was retracted and removed on September 24. Announcing the retraction, the journal editor stated that the article was being retracted…

Read More

Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects – Times of India

HYDERABAD: After AstraZeneca’s admitted in a UK court that its Covid-19 vaccine caused a rare side-effect — Thrombosis with Thrombocytopenia Syndrome (TTS), Hyderabad-based vaccine maker Bharat Biotech on Thursday stressed on the safety of its indigenous vaccine Covaxin to allay public concerns over Covid vaccines.AstraZeneca’s vaccine Vaxzevria, which it developed in collaboration with Oxford University,…

Read More